Ovarian, Fallopian Tube, and Peritoneal Cancer Outcomes
Between 2015-2019, the five-year survival rate for ovarian, fallopian tube, and peritoneal cancer at KFSYSCC was 73.0%.
Basic Information and Distribution of 560 Ovarian, Fallopian Tube, and Peritoneal Cancer Patients at KFSYSCC from 1990-2019
| Total | 1990-1994 | 1995-1999 | 2000-2004 | 2005-2009 | 2010-2014 | 2015-2019 | |
|---|---|---|---|---|---|---|---|
| n | 560 | 5 (1%) | 25 (4%) | 87 (16%) | 132 (24%) | 155 (28%) | 156 (28%) |
| Age | |||||||
| Mean/Median | 51/52 | 52/58 | 54/55 | 50/51 | 52/52 | 52/53 | 51/52 |
| Range | 14-90 | 34-63 | 24-83 | 17-80 | 17-82 | 18-78 | 14-90 |
| Q1-Q3 | 44-60 | 42-62 | 45-64 | 43-59 | 43-60 | 44-59 | 44-60 |
| Stage (%) | |||||||
| I | 189 (34%) | 0 (0%) | 3 (12%) | 22 (25%) | 45 (34%) | 52 (34%) | 67 (43%) |
| II | 37 (7%) | 1 (20%) | 0 (0%) | 5 (6%) | 8 (6%) | 11 (7%) | 12 (8%) |
| III | 138 (25%) | 1 (20%) | 3 (12%) | 23 (26%) | 41 (31%) | 35 (23%) | 35 (22%) |
| IV | 137 (24%) | 1 (20%) | 7 (28%) | 8 (9%) | 32 (24%) | 53 (34%) | 36 (23%) |
| Unknown | 59 (11%) | 2 (40%) | 12 (48%) | 29 (33%) | 6 (5%) | 4 (3%) | 6 (4%) |
Based on KFSYSCC's cancer registry from 1990 to 2019, there were 560 analytic ovarian, fallopian tube, and peritoneal cancer cases. The average and median ages were 51 and 52 years old, respectively; the youngest patient was 14 years old, and the oldest was 90 years old; the interquartile range (Q1-Q3) was 44-60. By stage, there were 189 stage I patients (34%), 37 stage II patients (7%), 138 stage III patients (25%), and 137 stage IV patients (24%). The table below presents the basic patient information and stage distribution, categorized by the year of diagnosis.
Survival Curves for 560 Ovarian, Fallopian Tube, and Peritoneal Cancer Patients (1990-2019), Stratified by Year of Diagnosis
From 1990 to 2019, the chart illustrates the five-year observed survival rates for 560 ovarian, fallopian tube, and peritoneal cancer patients at KFSYSCC, stratified by the year of diagnosis. The graph shows the five-year survival rate increased from 42% in 1990-1994 to 73% in 2015-2019, while the ten-year survival rate rose from 30% in 1990-1994 to 63% in 2010-2014.
Treatment Methods and Stages for 156 Ovarian, Fallopian Tube, and Peritoneal Cancer Patients at KFSYSCC (2015-2019)
| Treatment/Stage | Total | Stage I | Stage II | Stage III | Stage IV | Unknown |
|---|---|---|---|---|---|---|
| Total | 156 | 67 | 12 | 35 | 36 | 6 |
| Surgical Treatment | 144 (92%) | 67 (100%) | 12 (100%) | 32 (91%) | 27 (75%) | 6 (100%) |
| Radiation Therapy | 3 (2%) | 2 (3%) | 0 (0%) | 0 (0%) | 1 (3%) | 0 (0%) |
| Chemotherapy | 119 (76%) | 39 (58%) | 11 (92%) | 32 (91%) | 35 (97%) | 2 (33%) |
| Targeted Therapy | 12 (8%) | 1 (1%) | 0 (0%) | 5 (14%) | 6 (17%) | 0 (0%) |
| Hormone Therapy | 1 (1%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (3%) | 0 (0%) |
| Immunotherapy | 0 (0%) | - | ||||
| Palliative Care | 7 (4%) | 0 (0%) | 0 (0%) | 2 (6%) | 5 (14%) | 0 (0%) |
| Bone Marrow/Stem Cell Transplant | 0 (0%) | - | ||||
| No Record of Initial Treatment Reported | 0 (0%) | - | ||||
Between 2015 and 2019, there were a total of 156 analytic ovarian, fallopian tube, and peritoneal cancer cases, including 67 patients in stage I, 12 in stage II, 35 in stage III, and 36 in stage IV. In terms of treatment methods, 144 patients (92%) underwent surgical treatment, 3 (2%) received radiation therapy, 119 (76%) underwent chemotherapy, 12 (8%) received targeted therapy, 1 (1%) received hormone therapy, and 7 (4%) underwent palliative care.
Five-Year Survival Rates of 156 Ovarian, Fallopian Tube, and Peritoneal Cancer Cancer Patients by Stage (2015-2019)
KFSYSCC’s 2015-2019 five-year observed survival rates for 156 ovarian, fallopian tube, and peritoneal cancer patients, stratified by stage, are presented in the accompanying chart. As shown in the graph, the five-year survival rate is 94% for stage 1, 78% for stage 2, 54% for stage 3, and 28% for stage 4.